| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |